The University of Queensland

Antibody-mediated interferences affecting cardiac troponin assays: recommendations from the IFCC Committee on Clinical Applications of Cardiac Biomarkers

Hammarsten, Ola, Warner, Janet V., Lam, Leo, Kavsak, Peter, Lindahl, Bertil, Aakre, Kristin M., Collinson, Paul, Jaffe, Allan S., Saenger, Amy K., Body, Richard, Mills, Nicholas L., Omland, Torbjørn, Ordonez-Llanos, Jordi and Apple, Fred S. (2023). Antibody-mediated interferences affecting cardiac troponin assays: recommendations from the IFCC Committee on Clinical Applications of Cardiac Biomarkers. Clinical Chemistry and Laboratory Medicine, 61 (8), 1411-1419. doi: 10.1515/cclm-2023-0028

Total bilirubin assay differences may cause inconsistent treatment decisions in neonatal hyperbilirubinaemia

Thomas, David H., Warner, Janet V., Jones, Graham R.D., Chung, Jason Z.Y., MacEy, David J., Screnci, Antonella and Ryan, Joshua B. (2022). Total bilirubin assay differences may cause inconsistent treatment decisions in neonatal hyperbilirubinaemia. Clinical Chemistry and Laboratory Medicine, 60 (11), 1736-1744. doi: 10.1515/cclm-2022-0749

High incidence of macrotroponin I with a high-sensitivity troponin I assay

Warner, Janet V. and Marshall, George A. (2016). High incidence of macrotroponin I with a high-sensitivity troponin I assay. Clinical Chemistry and Laboratory Medicine, 54 (11), 1821-1829. doi: 10.1515/cclm-2015-1276

Symptomatic hypocalcemia secondary to rifampicin-induced hypovitaminosis D

Leung, Clare, Warner, Janet, Harris, Mark and Nourse, Clare (2016). Symptomatic hypocalcemia secondary to rifampicin-induced hypovitaminosis D. Pediatric Infectious Disease Journal, 35 (7), 822-823. doi: 10.1097/INF.0000000000001169

Recovery of drugs of abuse from Drager DCD5000 oral fluid collection device in Australia

Hall, Ashley-Jane, Warner, Janet V., Henman, Michael G. and Ferguson, Wendy E. (2015). Recovery of drugs of abuse from Drager DCD5000 oral fluid collection device in Australia. Journal of Analytical Toxicology, 39 (2), 140-143. doi: 10.1093/jat/bku123

Familial isolated hyperparathyroidism is linked to a 1.7 Mb region on chromosome 2p13.3–14

Warner, J., Nyholt, D. R., Busfield, F., Epstein, M., Burgess, J., Stranks, S., Hill, P., Perry-Keene, D., Learoyd, D., Robinson, B., Teh, B. T., Prins, J. B. and Cardinal, J. W. (2006). Familial isolated hyperparathyroidism is linked to a 1.7 Mb region on chromosome 2p13.3–14. Journal of Medical Genetics, 43 (3), e12-e18. doi: 10.1136/jmg.2005.035766

A report of a national mutation testing service for the MEN1 gene: clinical presentations and implications for mutation testing

Cardinal, J. W., Bergman, L., Hayward, N., Sweet, A., Warner, J., Marks, L., Learoyd, D., Dwight, T., Robinson, B., Epstein, M., Smith, M., Teh, B. T., Cameron, D. P. and Prins, J. B. (2005). A report of a national mutation testing service for the MEN1 gene: clinical presentations and implications for mutation testing. Journal of Medical Genetics, 42 (1), 69-74. doi: 10.1136/jmg.2003.017319

Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications

Warner, J., Epstein, M., Sweet, A., Singh, D., Burgess, J., Stranks, S., Hill, P., Perry-Keene, D., Learoyd, D., Robinson, B., Birdsey, P., Mackenzie, E., Teh, B. T., Prins, J. B. and Cardinal, J. (2004). Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications. Journal of Medical Genetics, 41 (3), 155-160. doi: 10.1136/jmg.2003.016725